Phase III Clinical Trial of CinnaGen COVID-19 Vaccine (SpikoGen)
Clinical trial NCT05005559 · COMPLETED
Trial details
- NCT number
- NCT05005559
- Sponsor
- Cinnagen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-07
- Primary completion
- 2022-03-10
- Enrollment
- 16876
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.